To determine the association of Substance P marker level in blood and CSF in chronic pain patients
Not Applicable
- Conditions
- Health Condition 1: G894- Chronic pain syndrome
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with chronic pain syndromes,
Pain at least 6 months duration
Exclusion Criteria
Patients with a history of alcohol or drug abuse or with psycho-organic cerebral syndromes is excluded.
None of the patients had previously been taking narcotic analgesics.
Pain is not due to somatization disorder or major depression
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure Substance P level in blood in patients of chronic pain syndrome <br/ ><br>To measure Substance P level in CSF in patients of chronic pain syndrome <br/ ><br>To correlate the VAS score with the substance P level in serum and CSF level in patients of chronic pain syndrome. <br/ ><br>Timepoint: after 6 months of symptom onset <br/ ><br>single reading <br/ ><br>
- Secondary Outcome Measures
Name Time Method Assessment of demographic variation <br/ ><br> Variation in VAS of different types chronic pain syndromes <br/ ><br>Timepoint: Baseline, 4 weeks